Pulmonary endarterectomy for the treatment of chronic thromboembolic pulmonary hypertension

References

• Madani MM, Auger WR, Pretorius V, et al. Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. Ann Thorac Surg. 2012;94(1):97–103; discussion 103.
   PubMed Web of Science ®Google Scholar
• Simonneau G, Delcroix M, Lang I, et al. Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results of a prospective registry comparing operated versus non-operated patients. Am J Respir Crit Care Med. 2013;187:A5 365.
   Google Scholar
• Lewczuk J, Piszko P, Jagas J, et al. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest. 2001;119(3):818–823.
   PubMed Web of Science ®Google Scholar
• Riedel M, Stanek V, Widimsky J, et al. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest. 1982;81(2):151–158.
   PubMed Web of Science ®Google Scholar
• Jamieson SW, Kapelanski DP. Pulmonary endarterectomy. Curr Probl Surg. 2000;37(3):165–252.
   PubMedGoogle Scholar
• Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation. 1990;81(6):1735–1743.
   PubMed Web of Science ®Google Scholar
• Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350(22):2257–2264.
   PubMed Web of Science ®Google Scholar
• Dentali F, Donadini M, Gianni M, et al. Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res. 2009;124(3):256–258.
   PubMed Web of Science ®Google Scholar
• Wagenvoort CA. Pathology of pulmonary thromboembolism. Chest. 1995;107(1 Suppl):10S–17S.
   PubMed Web of Science ®Google Scholar
• Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009;34(6):1219–1263.
   PubMed Web of Science ®Google Scholar
• Lang IM, Pesavento R, Bonderman D, et al. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J. 2013;41(2):462–468.
   PubMed Web of Science ®Google Scholar
• Moser KM, Braunwald NS. Successful surgical intervention in severe chronic thromboembolic pulmonary hypertension. Chest. 1973;64(1):29–35.
   PubMed Web of Science ®Google Scholar
• Arbustini E, Morbini P, D’Armini AM, et al. Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation. Heart. 2002;88(2):177–182.
   PubMed Web of Science ®Google Scholar
• Blauwet LA, Edwards WD, Tazelaar HD, et al. Surgical pathology of pulmonary thromboendarterectomy: a study of 54 cases from 1990 to 2001. Hum Pathol. 2003;34(12):1290–1298.
   PubMed Web of Science ®Google Scholar
• Yi ES, Kim H, Ahn H, et al. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1577–1586.
   PubMed Web of Science ®Google Scholar
• Dartevelle P, Fadel E, Mussot S, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2004;23(4):637–648.
   PubMed Web of Science ®Google Scholar
• Lang IM, Klepetko W, Pabinger I. No increased prevalence of the factor V Leiden mutation in chronic major vessel thromboembolic pulmonary hypertension (CTEPH). Thromb Haemost. 1996;76(3):476–477.
   PubMed Web of Science ®Google Scholar
• Wolf M, Boyer-Neumann C, Parent F, et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J. 2000;15(2):395–399.
   PubMed Web of Science ®Google Scholar
• Bonderman D, Turecek PL, Jakowitsch J, et al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2003;90(3):372–376.
   PubMed Web of Science ®Google Scholar
• Bonderman D, Jakowitsch J, Adlbrecht C, et al. Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2005;93(3):512–516.
   PubMed Web of Science ®Google Scholar
• Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987;107(2):216–223.
   PubMed Web of Science ®Google Scholar
• Rubin LJ, Badesch DB. Evaluation and management of the patient with pulmonary arterial hypertension. Ann Intern Med. 2005;143(4):282–292.
   PubMed Web of Science ®Google Scholar
• Pepke-Zaba J, Delcroix M, Lang I, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011;124(18):1973–1981.
   PubMed Web of Science ®Google Scholar
• Becattini C, Agnelli G, Pesavento R, et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest. 2006;130(1):172–175.
   PubMed Web of Science ®Google Scholar
• Kim NH, Delcroix M, Jenkins DP, et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D92–D99.
   PubMed Web of Science ®Google Scholar
• Jenkins D, Mayer E, Screaton N, et al. State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management. Eur Respir Rev. 2012;21(123):32–39.
   PubMedGoogle Scholar
• Raisinghani A, Ben-Yehuda O. Echocardiography in chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg. 2006;18(3):230–235.
   PubMedGoogle Scholar
• Menzel T, Kramm T, Bruckner A, et al. Quantitative assessment of right ventricular volumes in severe chronic thromboembolic pulmonary hypertension using transthoracic three-dimensional echocardiography: changes due to pulmonary thromboendarterectomy. Eur J Echocardiogr. 2002;3(1):67–72.
   PubMedGoogle Scholar
• Klok FA, Huisman MV. Epidemiology and management of chronic thromboembolic pulmonary hypertension. Neth J Med. 2010;68(9):347–351.
   PubMed Web of Science ®Google Scholar
• Kim NH. Assessment of operability in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006;3(7):584–588.
   PubMedGoogle Scholar
• Tunariu N, Gibbs SJ, Win Z, et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med. 2007;48(5):680–684.
   PubMed Web of Science ®Google Scholar
• Skoro-Sajer N, Becherer A, Klepetko W, et al. Longitudinal analysis of perfusion lung scintigrams of patients with unoperated chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2004;92(1):201–207.
   PubMed Web of Science ®Google Scholar
• Fedullo PF, Auger WR, Kerr KM, et al. Chronic thromboembolic pulmonary hypertension. N Engl J Med. 2001;345(20):1465–1472.
   PubMed Web of Science ®Google Scholar
• Hoeper MM, Mayer E, Simonneau G, et al. Chronic thromboembolic pulmonary hypertension. Circulation. 2006;113(16):2011–2020.
   PubMed Web of Science ®Google Scholar
• Claessen G, La Gerche A, Dymarkowski S, et al. Pulmonary vascular and right ventricular reserve in patients with normalized resting hemodynamics after pulmonary endarterectomy. J Am Heart Assoc. 2015;4(3):e001602.
   PubMed Web of Science ®Google Scholar
• Hoeper MM, Barbera JA, Channick RN, et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol. 2009;54(1 Suppl):S85–S96.
   PubMed Web of Science ®Google Scholar
• Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119.
   Google Scholar
• Kim NH, Fesler P, Channick RN, et al. Preoperative partitioning of pulmonary vascular resistance correlates with early outcome after thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Circulation. 2004;109(1):18–22.
   PubMed Web of Science ®Google Scholar
• Toshner M, Suntharalingam J, Fesler P, et al. Occlusion pressure analysis role in partitioning of pulmonary vascular resistance in CTEPH. Eur Respir J. 2012;40(3):612–617.
   PubMed Web of Science ®Google Scholar
• Mayer E, Jenkins D, Lindner J, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011;141(3):702–710.
   PubMed Web of Science ®Google Scholar
• Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003;76(5):1457–1462; discussion 1462–1454.
   PubMed Web of Science ®Google Scholar
• Remy-Jardin M, Duhamel A, Deken V, et al. Systemic collateral supply in patients with chronic thromboembolic and primary pulmonary hypertension: assessment with multi-detector row helical CT angiography. Radiology. 2005;235(1):274–281.
   PubMed Web of Science ®Google Scholar
• Hoey ET, Mirsadraee S, Pepke-Zaba J, et al. Dual-energy CT angiography for assessment of regional pulmonary perfusion in patients with chronic thromboembolic pulmonary hypertension: initial experience. AJR. 2011;196(3):524–532.
   PubMed Web of Science ®Google Scholar
• Klepetko W, Mayer E, Sandoval J, et al. Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):73S–80S.
   PubMed Web of Science ®Google Scholar
• Taboada D, Pepke-Zaba J, Jenkins DP, et al. Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease. Eur Respir J. 2014;44(6):1635–1645.
   PubMed Web of Science ®Google Scholar
• Naeije R, Vanderpool R, Dhakal BP, et al. Exercise-induced pulmonary hypertension: physiological basis and methodological concerns. Am J Respir Crit Care Med. 2013;187(6):576–583.
   PubMed Web of Science ®Google Scholar
• Herve P, Lau EM, Sitbon O, et al. Criteria for diagnosis of exercise pulmonary hypertension. Eur Respir J. 2015;46(3):728–737.
   PubMed Web of Science ®Google Scholar
• Houston BA, Tedford RJ. Putting “At-Rest” evaluations of the right ventricle to rest: insights gained from evaluation of the right ventricle during exercise in CTEPH patients with and without pulmonary endarterectomy. J Am Heart Assoc. 2016;4:3.
   Google Scholar
• Lau EM, Godinas L, Sitbon O, et al. Resting pulmonary artery pressure of 21-24 mmHg predicts abnormal exercise haemodynamics. Eur Respir J. 2016. doi:10.1183/13993003.01684-2015
   Google Scholar
• Jenkins DP, Madani M, Mayer E, et al. Surgical treatment of chronic thromboembolic pulmonary hypertension. Eur Respir J. 2013;41(3):735–742.
   PubMed Web of Science ®Google Scholar
• Banks DA, Pretorius GV, Kerr KM, et al. Pulmonary endarterectomy: part II. Operation, anesthetic management, and postoperative care. Semin Cardiothorac Vasc Anesth. 2014;18(4):331–340.
   PubMedGoogle Scholar
• Madani MM, Jamieson SW. Technical advances of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg. 2006;18(3):243–249.
   PubMedGoogle Scholar
• Hagl C, Khaladj N, Peters T, et al. Technical advances of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Eur J Cardiothorac Surg. 2003;23(5):776–781; discussion 781.
   PubMed Web of Science ®Google Scholar
• Macchiarini P, Kamiya H, Hagl C, et al. Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: is deep hypothermia required? Eur J Cardiothorac Surg. 2006;30(2):237–241; discussion 241–233.
   PubMed Web of Science ®Google Scholar
• Thomson B, Tsui SS, Dunning J, et al. Pulmonary endarterectomy is possible and effective without the use of complete circulatory arrest–the UK experience in over 150 patients. Eur J Cardiothorac Surg. 2008;33(2):157–163.
   PubMed Web of Science ®Google Scholar
• Jamieson S. Editorial Comment. Eur J Cardiothorac Surg. 2006;30:241–243.
   Web of Science ®Google Scholar
• Vuylsteke A, Sharples L, Charman G, et al. Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial. Lancet. 2011;378(9800):1379–1387.
   PubMed Web of Science ®Google Scholar
• Freed DH, Thomson BM, Berman M, et al. Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg. 2011;141(2):383–387.
   PubMed Web of Science ®Google Scholar
• Corsico AG, D’Armini AM, Cerveri I, et al. Long-term outcome after pulmonary endarterectomy. Am J Respir Crit Care Med. 2008;178(4):419–424.
   PubMed Web of Science ®Google Scholar
• Condliffe R, Kiely DG, Gibbs JS, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008;177(10):1122–1127.
   PubMed Web of Science ®Google Scholar
• Kunieda T, Nakanishi N, Satoh T, et al. Prognoses of primary pulmonary hypertension and chronic majorvessel thromboembolic pulmonary hypertension determined from cumulative survival curves. Intern Med. 1999;38(7):543–546.
   PubMed Web of Science ®Google Scholar
• Jamieson SW, Auger WR, Fedullo PF, et al. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. J Thorac Cardiovasc Surg. 1993;106(1):116–126; discussion 126–117.
   PubMed Web of Science ®Google Scholar
• Freed DH, Thomson BM, Tsui SS, et al. Functional and haemodynamic outcome 1 year after pulmonary thromboendarterectomy. Eur J Cardiothorac Surg. 2008;34(3):525–529; discussion 529–530.
   PubMed Web of Science ®Google Scholar
• Kerr KM, Auger WR, Marsh JJ, et al. The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 2000;162(1):14–20.
   PubMed Web of Science ®Google Scholar
• Levinson RM, Shure D, Moser KM. Reperfusion pulmonary edema after pulmonary artery thromboendarterectomy. Am Rev Respir Dis. 1986;134(6):1241–1245.
   PubMed Web of Science ®Google Scholar
• Manecke GR Jr, Kotzur A, Atkins G, et al. Massive pulmonary hemorrhage after pulmonary thromboendarterectomy. Anesth Analg. 2004;99(3):672–675, table of contents.
   PubMed Web of Science ®Google Scholar
• Kerr KM, Auger WR, Marsh JJ, et al. Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy. Chest. 2012;141(1):27–35.
   PubMed Web of Science ®Google Scholar
• Guerin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159–2168.
   PubMed Web of Science ®Google Scholar
• Berman M, Tsui S, Vuylsteke A, et al. Successful extracorporeal membrane oxygenation support after pulmonary thromboendarterectomy. Ann Thorac Surg. 2008;86(4):1261–1267.
   PubMed Web of Science ®Google Scholar
• Kimmoun A, Guerci P, Bridey C, et al. Prone positioning use to hasten veno-venous ECMO weaning in ARDS. Intensive Care Med. 2013;39(10):1877–1879.
   PubMed Web of Science ®Google Scholar
• Thistlethwaite PA, Madani MM, Kemp AD, et al. Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes. Ann Thorac Surg. 2006;82(6):2139–2145.
   PubMed Web of Science ®Google Scholar
• Duwe BV, Kerr KM, Fedullo P, et al. Clinical impact of reperfusion lung injury on patients undergoing pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 2009;179:A4628.
   Google Scholar
• Mares P, Gilbert TB, Tschernko EM, et al. Pulmonary artery thromboendarterectomy: a comparison of two different postoperative treatment strategies. Anesth Analg. 2000;90(2):267–273.
   PubMed Web of Science ®Google Scholar
• Bonderman D, Skoro-Sajer N, Jakowitsch J, et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation. 2007;115(16):2153–2158.
   PubMed Web of Science ®Google Scholar
• Jenkins D. Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2015;24(136):263–271.
   PubMedGoogle Scholar
• Jensen KW, Kerr KM, Fedullo PF, et al. Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation. 2009;120(13):1248–1254.
   PubMed Web of Science ®Google Scholar
• Jais X, D’Armini AM, Jansa P, et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol. 2008;52(25):2127–2134.
   PubMed Web of Science ®Google Scholar
• Ghofrani HA, D’Armini AM, Grimminger F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013;369(4):319–329.
   PubMed Web of Science ®Google Scholar
• Feinstein JA, Goldhaber SZ, Lock JE, et al. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation. 2001;103(1):10–13.
   PubMed Web of Science ®Google Scholar
• Pitton MB, Herber S, Mayer E, et al. Pulmonary balloon angioplasty of chronic thromboembolic pulmonary hypertension (CTEPH) in surgically inaccessible cases. RoFo. 2003;175(5):631–634.
   PubMedGoogle Scholar
• Ogo T. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension. Curr Opin Pulm Med. 2015;21(5):425–431.
   PubMed Web of Science ®Google Scholar
• Ogawa A, Kitani M, Mizoguchi H, et al. Pulmonary microvascular remodeling after balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension. Internal Medicine (Tokyo, Japan). 2014;53(7):729–733.
   PubMed Web of Science ®Google Scholar
• Bouvaist H, Thony F, Jondot M, et al. Balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2014;23(133):393–395.
   PubMedGoogle Scholar
• Mizoguchi H, Ogawa A, Munemasa M, et al. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5(6):748–755.
   PubMed Web of Science ®Google Scholar
• Kataoka M, Inami T, Hayashida K, et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5(6):756–762.
   PubMed Web of Science ®Google Scholar
• Sugimura K, Fukumoto Y, Satoh K, et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J. 2012;76(2):485–488.
   PubMed Web of Science ®Google Scholar
• Wiedenroth CB, Liebetrau C, Breithecker A, et al. Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2015. doi:10.1016/j.healun.2015.10.030
   PubMedGoogle Scholar
• Inami T, Kataoka M, Shimura N, et al. Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty. JACC Cardiovasc Interv. 2013;6(7):725–736.
   PubMed Web of Science ®Google Scholar